Back to Bills
HOUSE-BILL 2767119th Congress

HOUSE-BILL 2767: H.R.2767 - BRAIN Act

Introduced: April 9, 2025
Status: Referred to Committee
supported

AI-Powered Summary

Generated by AI Analysis

HOUSE-BILL 2767 aims to enhance research and treatment options for individuals diagnosed with brain tumors, focusing on improving health outcomes and quality of life. The bill addresses major themes of health care access, public awareness, and patient empowerment by promoting initiatives for better access to clinical trials and treatment options. Key provisions include increased funding for brain tumor research, the establishment of a national public awareness campaign about clinical trials and biomarker testing, and the introduction of pilot programs for monitoring and supporting brain tumor survivors. Implementation requirements involve the allocation of federal funds and the establishment of oversight mechanisms to ensure compliance with health care regulations. Potential impacts include improved access to specialized cancer care, enhanced patient knowledge and resources, and possible constitutional concerns regarding funding allocation and federal authority in health care regulation.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill has significant positive implications for individuals, particularly those diagnosed with brain tumors, by potentially increasing their access to treatment and improving health outcomes. It emphasizes inclusivity and aims to address disparities in healthcare access, which is a critical constitutional concern.

Key Individual Rights

  • Right to Health Care
  • Equal Protection under the Law
  • Right to Information and Awareness

Constitutional Provisions

  • Fourteenth Amendment - Due Process Clause
  • Fourteenth Amendment - Equal Protection Clause
  • First Amendment - Free Speech

Potential Constitutional Challenges

While the bill promotes equal access, there may be challenges regarding the implementation of its provisions, particularly if disparities in access to clinical trials or treatments arise based on socioeconomic status or geographic location. Additionally, the balance between public health initiatives and individual rights to privacy and informed consent may raise concerns.

Summary

HOUSE-BILL 2767 aims to enhance research and treatment options for brain tumors, directly impacting individuals across various demographic categories. By focusing on vulnerable populations and promoting equitable access to healthcare resources, the bill aligns with constitutional principles of equal protection and due process. However, careful implementation is necessary to avoid potential disparities and uphold individual rights.

Constitutional Analysis

supported

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention H.R. 2767 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Policy Topics

Timeline

April 9, 2025

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat